Clinical characteristics and referral pattern of patients with left ventricular dysfunction and significant coronary artery disease undergoing radionuclide imaging

Journal of Nuclear Cardiology

Volumn 11, Issue 2, 2004, Pages 118-125

  Bourque, Jamieson M ^a   Velazquez, Eric J ^a   Borges Neto, Salvador ^a   Shaw, Linda K ^a   Whellan, David J ^a   O'Connor, Christopher M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Left ventricular dysfunction; Myocardial viability; Radionuclide perfusion imaging; Referral pattern

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DISEASE SEVERITY; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICULOGRAPHY; HUMAN; IMAGE ANALYSIS; KRUSKAL WALLIS TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; EPIDEMIOLOGY; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; REGRESSION ANALYSIS; RESEARCH; SCINTISCANNING; STATISTICS;

AGED; COHORT STUDIES; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; REFERRAL AND CONSULTATION; REGRESSION ANALYSIS; RESEARCH; SELECTION BIAS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2542491384     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2003.09.005     Document Type: Article

References (32)

1. American Heart Association 2003 Heart and stroke statistical update. Dallas: American Heart Association; 2003
2. Mosterd A. Cost B. Hoes A.W. et al. The prognosis of heart failure in the general population: the Rotterdam Study Eur Heart J 22 2001 1318-1327
3. Brundage B.H. Massie B.M. Botvinick E.H. Improved regional ventricular function after successful surgical revascularization J Am Coll Cardiol 3 1984 902-908
4. vom Dahl J. Eitzman D.T. al-Aouar Z.R. et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization Circulation 90 1994 2356-2366
5. Rahimtoola S.H. The hibernating myocardium Am Heart J 117 1989 211-221
6. al Mohammad A. Mahy I.R. Norton M.Y. et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles Heart 80 1998 559-564
7. Gonzalez J.M. Castell-Conesa J. Candell-Riera J. Rossello-Urgell J. Spanish W. Relevance of 99mTc-MIBI rest uptake, ejection fraction and location of contractile abnormality in predicting myocardial recovery after revascularization Nucl Med Commun 22 2001 795-805
8. Gioia G. Powers J. Heo J. Iskandrian A.S. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy Am J Cardiol 75 1995 759-762
9. Bart B.A. Shaw L.K. McCants C.B.J. et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy J Am Coll Cardiol 30 1997 1002-1008
10. Lee K.L. Pryor D.B. Pieper K.S. et al. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables Circulation 82 1990 1705-1717
11. Maes A.F. Borgers M. Flameng W. et al. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up J Am Coll Cardiol 29 1997 62-68
12. Cuocolo A. Acampa W. Nicolai E. et al. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction J Nucl Cardiol 7 2000 8-15
13. Bourque J. Velazquez E. Borges-Neto S. et al. Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? Am Heart J 145 2003 758-767
14. Paolini G. Lucignani G. Zuccari M. et al. Identification and revascularization of hibernating myocardium in angina-free patients with left ventricular dysfunction Eur J Cardiothorac Surg 8 1994 139-144
15. O'Connor C. Gattis W. Shaw L. Cuffe M. Califf R. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function Am J Cardiol 86 2000 863-867
16. Borges-Neto S. Coleman R.E. Jones R.H. Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers J Nucl Med 31 1990 1128-1132
17. Borges-Neto S. Javaid A. Shaw L.K. et al. Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol Radiology 215 2000 529-533
18. Khan S.S. Nessim S. Gray R. et al. Increased mortality of women in coronary artery bypass surgery: evidence for referral bias Ann Intern Med 112 1990 561-567
19. Bloemenkamp K.W. Rosendaal F.R. Buller H.R. et al. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias Arch Intern Med 159 1999 65-70
20. Chan R.K. Raman J. Lee K.J. et al. Prediction of outcome after revascularization in patients with poor left ventricular function Ann Thorac Surg 61 1996 1428-1434
21. Petretta M. Cuocolo A. Bonaduce D. et al. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction J Nucl Med 38 1997 195-200
22. Pasquet A. Robert A. D'Hondt A.M. et al. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction Circulation 100 1999 141-148
23. Di Carli M.F. Davidson M. Little R. et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction Am J Cardiol 73 1994 527-533
24. Zhang X. Liu X.J. Wu Q. et al. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET J Nucl Med 42 2001 1166-1173
25. Bax J.J. Visser F.C. Poldermans D. et al. Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms J Nucl Med 42 2001 79-86
26. Petretta M. Cuocolo A. Nicolai E. et al. Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction J Nucl Cardiol 5 1998 378-386
27. Mark D.B. Shaw L.K. Delong E.R. Califf R.M. Pryor D.B. Absence of sex bias in the referral of patients for cardiac catheterization N Engl J Med 330 1994 1101-1106
28. Peterson E.D. Shaw L.K. Delong E.R. et al. Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med 336 1997 480-486
29. Strauss R. Pfeifer C. Muhlberger V. Ulmer H. Pfeiffer K.P. Effects of morbidity, age, gender and region on percutaneous transluminal coronary angioplasty (PTCA) utilisation Public Health 113 1999 79-87
30. Harris P.J. Harrell F.E.J. Lee K.L. Behar V.S. Rosati R.A. Survival in medically treated coronary artery disease Circulation 60 1979 1259-1269
31. Borges-Neto S. Coleman R.E. Potts J.M. Jones R.H. Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease Semin Nucl Med 21 1991 223-229
32. D'Hoore W. Sicotte C. Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index Methods Inf Med 32 1993 382-387